NoyMed
Private Company
Funding information not available
Overview
NoyMed is a European, privately-held CRO specializing in biometrics and clinical operations services for the life sciences industry. The company leverages a distributed team across multiple time zones to offer scalable, tailored solutions for clinical data management, statistical analysis, and regulatory writing. While it does not develop its own therapeutics, it provides critical outsourced services that accelerate drug and device development for its clients, with a particular noted expertise in oncology, neurology, and respiratory trials. Its business model is purely service-based, generating revenue from client contracts.
Technology Platform
Service-based platform utilizing industry-standard SAS programming and CDISC standards, partnered with the TrialKit EDC (Electronic Data Capture) software for web-based, mobile, and wearable-enabled clinical data collection.
Opportunities
Risk Factors
Competitive Landscape
NoyMed competes in the fragmented CRO market against large full-service players (e.g., IQVIA, Parexel) and many small-to-mid-sized specialized CROs. Its differentiation is its focused expertise in biometrics within a broader service offering and its cost-effective positioning from its European base.